Flu Vaccines
Sinovac Reports Unaudited Second Quarter 2009 Financial Results
Published in TB and Outbreaks Week, September 1st, 2009
Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, announced its unaudited financial results for the three-month and six- month periods ended June 30, 2009. Financial Highlights -- Sales for the quarter increased 21% to $20.0 million -- Sales for the six-month period increased 5% to $26.6 million -- Operating income for the quarter rose 52% to $10.7 million -- Operating income for the six-month period increased 11% to
$11.3 million. -- Net income attributable to the shareholders increased 74% to
$5.8 million in the second quarter, with diluted EPS of $0.14 -- Cash and cash equivalents at June 30, 2009...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Biopharmaceuticals
Helix BioPharma Announces the Appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its Board of Directors - Apoptosis
Findings from Kyushu University in apoptosis reported - Arthralgia
New research on arthralgia from S.D. Suryawanshi and co-authors summarized - Biochemistry
Research conducted at University of Bern has provided new information about biochemistry - Bird Flu
New bird flu data have been reported by M. Rajik and co-authors - Cervical Lymphadenopathy
Study results from R. Khan and colleagues update understanding of cervical lymphadenopathy - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
